KRAS and cancer: Indeed, telomerase abrogation in the context of cancer-prone mouse models, including the K-Ras+/G12D lung tumorigenesis mouse model, only showed anti-tumorigenic activity after several mouse generations in the absence of telomerase when telomeres reached a critically short length [67, 72–74].